हिंदी में पढ़ें

Sun Pharma

Sun Pharma Shares Hit 52-Week High Post Acquiring Israel's Libra Merger Ltd | Stock Market News

Sun Pharma Shares Hit 52-Week High Post Acquiring Israel's Libra Merger Ltd | Stock Market News

Wed, Jan 03, 2024

Sun Pharma hits a new high after acquiring Israel's Libra Merger, consolidating its presence in the region. This follows a recent US investment in Lyndra Therapeutics. We break down the deals and their potential impact on Sun Pharma's future.

How will be the results of SunPharma?

How will be the results of SunPharma?

Tue, Oct 31, 2023

How will SunPharma's results be? How will be the growth in domestic formulations? How much income is possible from America? Know complete details from Nupur.

Stocks in Focus on November 22: CSB bank, RITES to BHEL; here are the 5 Newsmakers of the Day

Stocks in Focus on November 22: CSB bank, RITES to BHEL; here are the 5 Newsmakers of the Day

Fri, Nov 22, 2019

The market snapped its two-day winning run and ended with modest losses on Thursday, November 21, 2019, but stock-specific movements kept the traders busy throughout the day. But certain stocks came in news after the market was closed for trading purposes.

TRENDING NOW

Sensex climbs over 110 points after Asian uptrend

Sensex climbs over 110 points after Asian uptrend

Thu, Aug 24, 2017

dian stocks today shrugged off weakness in US markets as the Sensex surged over 110 points, with domestic investors doing the job amid positive Asian cues.

Good news for Sun Pharma from US; IPO of Reliance Gen Insurance to come soon

Good news for Sun Pharma from US; IPO of Reliance Gen Insurance to come soon

Tue, Jun 13, 2017

This segment of Share Bazaar brings to you exclusive update about Sun Pharma. Suggestions from experts for today's trading and many important news updates are also featured in this segment. About Zee Business --------------------------

Sensex bounces back by 195 points, Nifty rises above 9,600-mark in early trade

Sensex bounces back by 195 points, Nifty rises above 9,600-mark in early trade

Fri, Jun 02, 2017

The key equity indices of Indian markets- Sensex and Nifty- have resumed their record-setting spree and have recovered to fresh lifetime highs in opening trade on Friday on sustained buying amid positive global cues.

Sun Pharma break down by 13% due to weak results and bad outlook

Sun Pharma break down by 13% due to weak results and bad outlook

Mon, May 29, 2017

Sun Pharma break down by 13% due to weak results and bad outlook. Watch this special segment and get to know more here.

Sun Pharma shares touch new lows as pricing pressure in US continues

Sun Pharma shares touch new lows as pricing pressure in US continues

Mon, May 29, 2017

Sun Pharma's fourth quarter results have been disappointing. The company said that pricing pressure in its US generic operation will continue for more time. Analysts, in the meantime, have begun downgrading the stock.

Sun Pharma says sales may fall in 2018 as US market gets tougher for generic drugs

Sat, May 27, 2017

Sun Pharmaceutical Industries MD Dilip Shanghvi has said on Friday that the US sales might fall in 2018 because of pressure on drug prices, signalling tough market conditions in the United States (US) for generic drugmakers.

Indian equities bullish on IMD forecast, indices scale record highs

Indian equities bullish on IMD forecast, indices scale record highs

Sat, May 13, 2017

The key Indian equity indices zoomed to new closing and 52-week highs, crossing their psychologically significant levels, riding on news reports which quoted a top India Meteorological Department (IMD) official predicting a higher rainfall than previously forecast as the El Nino weather condition had eased.

Sun Pharma shares rise as USFDA clears Mohali facility

Sun Pharma shares rise as USFDA clears Mohali facility

Tue, Mar 14, 2017

Sun Pharma said, “It's subsidiaries or associate was informed by the US FDA yesterday, that it will lift the import alert imposed on the Mohali (Punjab) manufacturing facility and remove the facility from the official action initiated (OAI) status."

Stocks of Sun Pharma, TCS, Infosys and Tech Mahindra are the Nifty Gainers

Stocks of Sun Pharma, TCS, Infosys and Tech Mahindra are the Nifty Gainers

Thu, Feb 16, 2017

Stocks of Sun Pharma, TCS, Infosys and Tech Mahindra are the Nifty Gainers. Watch this special segment and get to know more here.

Two killed in fire at Sun Pharma factory

Two killed in fire at Sun Pharma factory

Wed, Dec 28, 2016

A fire broke out in the Sun Pharma factory in Ahmednagar on Wednesday, claiming two lives while two were injured.

Sun Pharma arm picks up 14.6% stake in US company for $13 million

Sun Pharma arm picks up 14.6% stake in US company for $13 million

Fri, Dec 23, 2016

"...One of the wholly-owned subsidiaries of the company has acquired 13,000,000 Series B preferred stock of scPharmaceuticals Inc (equivalent to 14.58% fully diluted equity stake on conversion) by way of allotment," Sun Pharmaceutical Industries said in a BSE filing.

Sun Pharma to acquire oncology product from Novartis for $175 million; stock up 0.5%

Sun Pharma to acquire oncology product from Novartis for $175 million; stock up 0.5%

Thu, Dec 22, 2016

"Odomzo gives us an opportunity to meaningfully expand our already established branded dermatology business and support our expansion into branded oncology with a launched brand," Kirti Ganorkar, Global Head Business Development at Sun Pharma, said.

FDA made nine observations post Halol unit inspection: Sun Pharma

FDA made nine observations post Halol unit inspection: Sun Pharma

Thu, Dec 08, 2016

The company did not disclose the observations made by the USFDA.

Sun Pharma to acquire Russia's JSC Biosintez; shares up

Sun Pharma to acquire Russia's JSC Biosintez; shares up

Wed, Nov 23, 2016

“With this move, we plan to acquire the product portfolio and local manufacturing capability in Russia which would help in expanding our presence in Russia and serving Russia pharmaceutical market more effectively,” Sun Pharma said in a statement.

Higher spending, urbanisation to boost domestic pharma markets: Fitch

Higher spending, urbanisation to boost domestic pharma markets: Fitch

Tue, Nov 15, 2016

Increase in consumer spending in India would provide a boost to domestic pharmaceutical companies over the medium term, credit rating agency Fitch said.

WATCH:Top 5 stories of this morning; From Infosys to relocate 3,000 employees to RJio approaches TRAI over license breach by telcos

WATCH:Top 5 stories of this morning; From Infosys to relocate 3,000 employees to RJio approaches TRAI over license breach by telcos

Wed, Aug 17, 2016

Zee Business brings you the most important stories of the day that will help you shape your market strategies and keep you informed with the latest developments. Top five stories of this morning: 1. SGX Nifty in red amid weak global cues

Sun, Dr Reddy's, Glenmark strengthen their US play

Sun, Dr Reddy's, Glenmark strengthen their US play

Mon, Jul 18, 2016

Domestic pharma players are in stiff competition in US market. Sun Pharma with its taking over of SPARC's ELEPSIA XR, while Dr. Reddy launching Omeprazole and Sodium bicarbonate capsules and that of Glenmark waiting for 62 ANDA's approval, plans to strenghthen their position in the US.

Pharma likely to see double-digit revenue growth in first quarter

Pharma likely to see double-digit revenue growth in first quarter

Tue, Jul 12, 2016

Surya Patra and Mehul Sheth of Phillip Capital said, in Q1FY17, pharma industry to see top-line and bottom-line growth by 16% and 24% respectively, primarily due to robust performance from Sun Pharma, led by its product gGleevec.

These top six companies together added Rs 22,459 crore in market valuation

These top six companies together added Rs 22,459 crore in market valuation

Sun, Jun 19, 2016

Sun Pharma added Rs 288.8 crore to Rs 1,78,769.24 crore.

Sun Pharma fourth quarter profit almost doubles but misses estimates

Sun Pharma fourth quarter profit almost doubles but misses estimates

Tue, May 31, 2016

Net profit for the world`s fifth-largest generic drugs maker in the January-March quarter jumped to 17.1 billion rupees ($255 million) from 8.9 billion rupees in the same period a year earlier. But that was below a Thomson Reuters StarMine SmartEstimate of 19.14 billion rupees.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x